OrbiMed is a Venture Capital based in New York.

How many investments has OrbiMed made?

OrbiMed has made 282 disclosed investments.

How much does OrbiMed manage?

OrbiMed manages $18.3B in assets.

What does OrbiMed invest in?

OrbiMed invests in Biotech, Healthcare, Life Sciences, Medical Devices, Digital Health Early Stage, Pre-Seed, Seed, Late Stage, Growth, Public companies.

What companies has OrbiMed invested in?

OrbiMed's portfolio includes Perfu, Crinetics Pharmaceuticals, Inc., DELFI Diagnostics, Ethris, Zylox, HIRO.

OrbiMed

Venture Capital

Global Healthcare & Biopharma

New York, United States · 282+ investments · 211 portfolio companies

Website

Early Stage

Pre-Seed

Seed

Late Stage

Growth

Public

Biotech

Healthcare

Life Sciences

Medical Devices

Digital Health

Headquarters: New York, United States
Founded: 1989
Website: orbimed.com
AUM: $18.3B

Portfolio Companies: 211
Total Investments: 282
Last Investment: Jun 2026
Geographic Focus: United States, Asia, Europe, Israel, China, India

Investment Thesis

Invests globally across the healthcare industry from seed-stage VC to large publicly-traded companies via public equity, private equity, and private credit/royalty strategies.

OrbiMed is a Venture Capital firm based in New York, United States. It has made 282 investments in Biotech and Healthcare, including Perfu, Crinetics Pharmaceuticals, Inc. and DELFI Diagnostics.